MWNA
LEGN icon

Marshall Wace North America’s Legend Biotech LEGN Stock Holding History

Marshall Wace North America’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5.23M Sell
103,472
-359,052
-78% -$14.9M 0.02% 495
2021
Q2 		$19M Buy
462,524
+51,688
+13% +$1.76M 0.08% 265
2021
Q1 		$11.9M Buy
+410,836
New +$11.2M 0.05% 364
2020
Q3 		– Sell
-48,613
Closed -$2.07M – 1363
2020
Q2 		$2.07M Buy
+48,613
New +$1.9M 0.01% 586

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Marshall Wace North America's LEGN Position: Q3 2021 in Review

Marshall Wace North America reduced its Legend Biotech (LEGN) stake by 78% in Q3 2021, selling an estimated $14.9M and leaving 103,472 shares worth $5.23M. The position accounts for 0.02% of the portfolio, ranked #495.

Marshall Wace North America first reported a position in LEGN in Q2 2020 and has held it in 4 quarters since. The position peaked at $19M in Q2 2021. 88 funds tracked by Wall St. Rank hold LEGN as of Q3 2021.

  • Marshall Wace North America held 103,472 shares of Legend Biotech worth $5.23M as of Q3 2021.
  • Marshall Wace North America sold 359,052 Legend Biotech shares in Q3 2021, an estimated $14.9M.
  • Legend Biotech made up 0.02% of Marshall Wace North America's portfolio in Q3 2021, its #495 holding.
  • Marshall Wace North America first reported a position in Legend Biotech in Q2 2020 and has held it in 4 quarters since.
  • Marshall Wace North America's Legend Biotech position peaked at $19M in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.